TELO
Telomir Pharmaceuticals, Inc.
0.5950
+0.02 (+2.73%)
52w low 0.5450
1.58 high
4.8% of range
Financial Analysis
| Ratio | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Returns | |||||
| Return on Equity | 91.1% | -380.2% | -2,571.0% | -176.1% | |
| Return on Assets | -1,752.8% | -273.8% | -1,248.7% | -141.8% | |
| Return on Inv Capital | 72.0% | -255.1% | -1,498.1% | -139.1% | |
| Liquidity | |||||
| Current Ratio | 0.05x | 0.33x | 1.94x | 5.14x | |
| Quick Ratio | 0.05x | 0.33x | 1.94x | 5.14x | |
| Cash Ratio | 0.00x | 0.00x | 1.86x | 5.10x | |
| Leverage | |||||
| Debt / Equity | -- | 0.03x | -- | -- | |
| Net Debt / EBITDA | -- | -0.01x | -- | -- | |
| Interest Coverage | -- | -6.96x | -2.81x | -- | |
| Equity Multiplier | -0.05x | 1.39x | 2.06x | 1.24x | |
| Efficiency | |||||
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | |
| Op CF / Net Income | 0.55x | 0.30x | 0.31x | 0.35x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--